GlassScriptPhysician profile
Stephen Arthur Mcbride
NPI 1417211293
$9,901.46
in general payments reported to CMS, 2019-2025
22 companies · $22.30 in 2025
The $22.30 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $535 · 2020: $227 · 2021: $44.71 · 2022: $7,397 · 2023: $1,429 · 2024: $247 · 2025: $22.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,000 · Food and Beverage: $698.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,000.00 |
| Food and Beverage | $698.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,335.05 | 2019-2023 | Davinci Xi, Da Vinci Surgical System |
| Aroa Biosurgery Incorporated | $379.48 | 2022-2024 | |
| Organogenesis INC. | $302.24 | 2019-2020 | |
| Kerecis Limited | $247.75 | 2019-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Integra Lifesciences Corporation | $180.79 | 2019-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Melinta Therapeutics, LLC | $84.18 | 2019-2020 | |
| Polynovo North America LLC | $58.17 | 2022-2023 | |
| Heron Therapeutics, INC. | $34.58 | 2022 | |
| Merck Sharp & Dohme LLC | $32.05 | 2019 | |
| Myriad Genetic Laboratories, INC. | $29.34 | 2021 | |
| Baxter Healthcare | $28.53 | 2023 | |
| Cumberland Pharmaceuticals, INC. | $25.22 | 2019 | |
| Davol INC. | $22.42 | 2019 | |
| Octapharma USA, INC. | $22.30 | 2025 | Fibryga |
| Allergan, INC. | $18.33 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $18.01 | 2022 | |
| Medtronic, INC. | $16.37 | 2022 | |
| Ethicon US, LLC | $15.41 | 2019 | |
| Covidien LP | $14.68 | 2020 | |
| Osiris Therapeutics INC. | $13.44 | 2019 | |
| Misonix INC | $12.10 | 2020 | |
| Smith+Nephew, INC. | $11.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Mcbride listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.